| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.06B | 6.00B | 7.08B | 8.25B | 8.33B | 6.74B |
| Gross Profit | 2.26B | 1.94B | 3.22B | 3.88B | 4.08B | 2.71B |
| EBITDA | 1.22B | 888.20M | 2.54B | 3.22B | 3.01B | 1.88B |
| Net Income | 573.70M | 121.00M | 1.57B | 2.18B | 1.90B | 1.01B |
Balance Sheet | ||||||
| Total Assets | 12.01B | 12.52B | 14.09B | 13.22B | 11.98B | 9.63B |
| Cash, Cash Equivalents and Short-Term Investments | 2.40B | 2.55B | 2.99B | 2.48B | 2.92B | 1.35B |
| Total Debt | 3.01B | 3.47B | 3.37B | 3.36B | 3.23B | 3.10B |
| Total Liabilities | 4.69B | 4.83B | 5.28B | 5.41B | 5.77B | 5.02B |
| Stockholders Equity | 7.30B | 7.67B | 8.80B | 7.78B | 6.19B | 4.59B |
Cash Flow | ||||||
| Free Cash Flow | 1.45B | 1.42B | 1.21B | 438.40M | 1.60B | 1.29B |
| Operating Cash Flow | 1.40B | 1.76B | 1.91B | 1.98B | 2.63B | 1.78B |
| Investing Cash Flow | -340.30M | -538.50M | -1.01B | -1.74B | -705.40M | -915.10M |
| Financing Cash Flow | -1.81B | -1.76B | -683.80M | -686.50M | -370.00M | -569.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
87 Outperform | $5.38T | 26.37 | 104.37% | 0.02% | 65.47% | 66.12% | |
75 Outperform | $43.74B | 11.07 | 13.50% | 6.06% | 7.52% | 17.94% | |
74 Outperform | $39.52B | 59.92 | 6.66% | ― | 0.80% | ― | |
72 Outperform | $44.33B | ― | 7.45% | ― | -9.04% | -4.21% | |
68 Neutral | $75.88B | 26.48 | 14.45% | 2.29% | 15.55% | 43.35% | |
65 Neutral | $54.92B | 215.94 | 0.86% | 1.28% | 0.79% | -86.68% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |